CLINICAL_TRIALS
trial_result
· 2014-05-30
Clinical Trial Update: AGN-199201 for the Treatment of Erythema With Rosacea [Phase 2]
Summary
Phase 2 clinical trial update for AGN-199201 in erythema associated with rosacea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Rosacea, Erythema | Phase 2 | Status: COMPLETED | Results posted: 2014-05-30